Background: Cortical epidural stimulation is used for the treatment of different neuropsychiatric disorders such as chronic neuropathic pain, tinnitus, movement disorders, and psychiatric diseases. While preoperative magnetic resonance imaging (MRI) is considered the imaging tool of choice for planning the approach and electrode placement, postoperative MRI is still a contraindication with implanted paddle leads due to the risk of thermal damage or current induction creating seizures or neurological deficits. Objectives: In this feasibility in vitro study the temperature changes and induction were determined as well as the artifacts caused by 2 parallel paddle leads (Resume II, Model 3587 A; Medtronic, Minneapolis, Minn., USA), commonly used in clinical practice with and without a pulse generator (Prime Advanced, Model 7489; Medtronic). Methods: An ultrasound gel-filled head phantom with 2 paddle leads mimicking the surgical scenario was used to evaluate temperature changes as well as induced currents in a 1.5- and 3-tesla MR scanner. In addition, 1 patient underwent a 3-tesla MRI with an implanted subdural paddle lead. Results: Negligible temperature changes were detected with turbo spin echo sequences in the 1.5- and 3-tesla scanner using a head and body coil. Induced voltages up to 6 V were measured. The imaging artifacts in the phantom were well tolerable. The patient's imaging was uneventful under the settings which are accepted for deep brain stimulation imaging. Conclusion: MRI under the conditions described here seems to be safe with the implants used in this study. In particular, the induced temperature is much lower with paddle compared to conventional leads due to the different electrode design. The induced voltage does not carry any risks. However, these findings cannot automatically be transferred to other implants or other scanning conditions, and further studies are needed. The biomedical companies should be encouraged to develop MR-conditional paddle leads. Also, further research is necessary to study the mechanism of action of cortical stimulation in the future.

1.
Baker K, Nyenhuis JA, Hridlicka G, Rezai AR, Tkach JA, Shellock FG: Neurostimulator implants: assessment of magnetic field interactions associated with 1.5- and 3.0-tesla MR systems. J Magn Reson Imaging 2005;21:72-77.
2.
Baker KB, Tkach JA, Nyenhuis JA, Phillips M, Shellock FG, Gonzalez-Martinez J, Rezai AR: Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging 2004;20:315-320.
3.
Baker KB, Tkach J, Hall JD, Nyenhuis JA, Shellock FG, Rezai AR: Reduction of MRI-related heating in deep brain stimulation leads using a lead management system. Neurosurgery 2005;57:392-397.
4.
Baker KB, Tkach JA, Phillips MD, Rezai AR: Variability in RF-induced heating of a deep brain stimulation implant across MR systems. J Magn Reson Imaging 2006;24:1236-1242.
5.
Georgi A-C, Stippich C, Tronnier VM, Heiland S: Active deep brain stimulation during MRI: a feasibility study. Magn Reson Med 2004;51:380-388.
6.
Rezai AR, Phillips M, Baker K, Sharan AD, Nyenhuis J, Tkach J, Henderson J, Shellock FG: Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow guidelines. Invest Radiol 2004;39:300-303.
7.
Tronnier VM, Staubert A, Hähnel S, Sarem-Aslani A. Magnetic resonance imaging with implanted neurostimulators: an in-vitro and in-vivo study. Neurosurgery 1999;44:118-125.
8.
Zrinzo L, Yoshida F, Hariz MI, ThorntonJ, Foltynie T, Yousry TA, Limousin P: Clinical safety of brain magnetic resonance imaging with implanted deep brain stimulation hardware: large case series and review of the literature. World Neurosurg 2011;76:164-172.
9.
De Andres J, Valia JC, Cerda-Olmedo G, Quiroz C, Villanueva A, Martinez-Sanjuan V, de Leon-Casasola O: The safety of magnetic resonance imaging in patients with neurostimulation systems. Anesthesiology 2007;106:779-786.
10.
Mutter UM, Bellut D, Porchet F, Schuknecht B: Spinal magnetic resonance imaging with reduced specific absorption rate in patients harboring a spinal cord stimulation device - a single-centre prospective study analysing safety, tolerability and image quality. Acta Neurochir 2013;15:2327-2332.
11.
Chhabra V, Sung E, Mewes K, Bakay RAE, Abosch A, Gross RE: Safety of magnetic resonance imaging of deep brain stimulator systems: a serial imaging and clinical retrospective study. J Neurosurg 2010;112:497-502.
12.
Larson PS, Richardson RM, Starr PA, Martin AJ: Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg 2008;86:92-100.
13.
Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS: Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage 2009;47(suppl 2):T53-T57.
14.
Jung W, Zvereva V, Hajredini B, Jäckle SD: Initial experience with magnetic resonance imaging-safe pacemakers. J Interv Card Electrophysiol 2011;32:213-219.
15.
Medtronic: Risk Management Report for SureScan (MRI Compatible) Implantable Neurostimulation System and 1× 8 Vectris Percutaneous Leads. NDHF 1173-126742.
16.
Fontaine D, Hamani C, Lozano A: Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg 2009;110:251-256.
17.
Nuti C, Peyron R, Garcia-Larrea L, Brunon J, Laurent B, Sindou M, Mertens P: Motor cortex stimulation for neuropathic pain: four year outcome and predictors of efficacy. Pain 2006;118:43-52.
18.
Rasche D, Ruppolt M, Stippich C, Unterberg A, Tronnier V: Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10-year experience. Pain 2006;121:43-52.
19.
Melchert UH, Scholand-Engler HG, Erdmann CE, Bunke J, Tronnier V, Petersen D: Is it safe to examine patients with implanted DBS electrodes at 3 tesla? MAGMA 2011;24 (suppl 1):90.
20.
Finelli DA, Rezai AR, Ruggieri PM, Tkach JA, Nyenhuis JA, Hrdlicka G, Sharan A, Gonzales-Martinez J, Stypulkowski PH, Shellock FG: MR-imaging induced heating of deep brain stimulation electrodes: in vitro study. AJNR 2002;23:1795-1802.
21.
Rezai AR, Finelli D, Nyenhuis JA, Hrdlicka G, Tkach J, Ruggieri P, Stypulkowski PH, Shellock FG: Neurostimulator for deep brain stimulation: Ex vivo evaluation of MRI-related heating at 1.5 tesla. J Magn Reson Imaging 2002;15:241-250.
22.
Shellock FG. Radiofrequency energy-induced heating during MR procedures: a review. J Magn Reson Imaging 2000;12:30-36.
23.
Shrivastava D, Hughes J, Goerke U, DelaBarre L, Visaria R, Harel N, Vaughan JT: Heating induced near deep brain stimulation lead electrodes during magnetic resonance imaging with a 3 T transceive volume head coil. Phys Med Biol 2012;57:5651-5665.
24.
Shrivastava D, Abosch A, Hanson T, Tian J, Gupte A, Iaizzo PA, Vaughan JT: Effect of extra-cranial DBS lead on radiofrequency heating at 9.4 T (400.2 MHz). Phys Med Biol 2010;32:600-607.
25.
Gupte AA, Shrivastava D, Spaniol M, Abosch A: MRI-related heating near deep brain stimulation electrodes: more data are needed. Stereotact Funct Neurosurg 2011;89:131-140.
26.
Rezai AR, Baker K, Tkach J, Phillips M, Hrdlicka G, Sharan A, Nyenhuis JA, Ruggieri P, Shellock FG, Henderson J: Is magnetic resonance imaging safe for patients with neurostimulation systems used for deep brain stimulation (DBS)? Neurosurgery 2005;57:1056-1062.
27.
Bhidayasiri R, Bronstein JM, Sinha S, Krahl SE, Ahn S, Behnke EJ, Cohen MS, Frysinger R, Shellock FG: Bilateral neurostimulation systems used for deep brain stimulation: in vitro study of MRI-related heating at 1.5 tesla and implications for clinical imaging of the brain. Magn Reson Imaging 2005;23:549-555.
28.
Carmichael DW, Pinto S, Limousin-Dowsey P, Thobois S, Allen PJ, Lemieux L, Yousry Y, Thornton JS: Functional MRI with active, fully implanted, deep brain stimulation systems: safety and experimental confounds. Neuroimage 2007;37:508-517.
29.
Nizard J, Raoul S, Nguyen JP, Lefaucheur JP: Invasive stimulation for the treatment of refractory pain. Discov Med 2012;14:237-246.
30.
Osenbach RK: Motor cortex stimulation for intractable pain. Neurosurg Focus 2006;21:E6.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.